SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Reata Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of February 18, 2022 – RETA

NEW YORK, Dec. 28, 2021 /PRNewswire/ — The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Reata Pharmaceuticals, Inc. (“Reata” or the “Company”) (NASDAQ: RETA) between November 9, 2020 and…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.